All medical treatments for alcohol and opioid dependence must be used as part of a complete treatment plan that includes ongoing counseling and psychosocial support.
Lowers cravings for alcohol and opiates and prevents opiates from producing their enticing effects
Vivitrol is FDA-approved for the treatment of opioid and alcohol-use disorders. It is a 28-day, extended-release injectable of naltrexone, a β-endorphin antagonist. There is promising research showing decreased cravings for a variety of substances and even behavioral addictions (overeating, gambling, pornography) with Vivitrol treatment. www.vivitrol.com
Reduces withdrawal symptoms and diminishes cravings for opioids
Suboxone is FDA-approved for the treatment of opioid-use disorders. It is a combination of buprenorphine and naloxone, taken as a sublingual (under-the- tongue) tablet or film. It decreases cravings and allows more comfortable withdrawal, because it is a partial-agonist; it appeases opioid receptor sites in the nervous system. www.suboxone.com
For many patients, addiction is accompanied by conditions such as depression, anxiety, etc. Individuals may find that the inclusion of antidepressants or other carefully prescribed medications can greatly enhance their recovery experience and reduce the likelihood of relapse over time. Daylight Recovery’s onsite medical services collaborate directly with the clinical team. This proves to be tremendously advantageous to our patients with complex needs.
Generic and alternative forms of naltrexone, buprenorphine, and naloxone, on their own or combined with other therapeutic medications, are also available for use in addiction recovery. Our medical staff regularly assesses new advances in treatment and explores all good options with patients.
Medically Supervised Withdrawal Begins with a thorough assessment of vitals and evaluation of medical needs. The medical staff monitors withdrawal symptoms throughout the initial period of stabilization. Medical and clinical teams then together generate an appropriate treatment plan and transition to longer-term recovery.
Withdrawal from severe alcohol addiction and certain other drugs must be monitored in a hospital or specialized detox facility, because of potentially life- threatening health risks. If inpatient detox is deemed essential, Daylight Recovery partners with multiple licensed facilities in the area that perform best-in- class service. Following inpatient detox, treatment is carefully coordinated back to Daylight Recovery for continuing care.
Daylight Recovery believes that it is critical to the success of any treatment plan that medications be prescribed according to unique patient needs and not by presumed norms. Some patients may taper off recovery prescriptions within a few months, and others may take substantially longer, but the goal is always to eventually be free of medications, whatever the timeframe.
Onsite facilities include a full, private, medical examination room and a light-therapy room suitable for treating Seasonal Affective Disorder (SAD) and conducting cutting-edge color therapies for groups and individuals.
In addition to regular high-complexity urine screenings, a typical part of most treatment programs, Daylight Recovery offers testing that can have a profound impact on the value of our medical services. This can include full blood work- ups to screen for things like hormone levels and liver function. We also offer DNA/pharmacogenetic testing that characterizes an individual body’s response to specific medications. This helps predict both effectiveness and potential side effects of prescriptions used in treatment.